Giovanni Caruso Partner   345 Park Avenue
New York, NY 10154 Direct    212.407.4866
Main      212.407.4000
Fax         212.937.3943
gcaruso@loeb.com

Via Edgar

September 23, 2021

John Spitz
Amit Pande
Division of Corporation Finance
Office of Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549

Re: Goldenstone Acquisition Limited

Amendment No. 1 to Registration Statement on Form S-1

Filed August 24, 2021

File No. 333-257209

Dear Mr. Spitz and Mr. Pandi:

On behalf of our client, Goldenstone Acquisition Limited, a Delaware corporation (the “Company”), we submit to the staff (the “Staff”) of the U.S. Securities and Exchange Commission (the “SEC”) this letter setting forth the Company’s response to the comment contained in the Staff’s letter dated September 13, 2021 (the “Comment Letter”) regarding Amendment No. 1 (“Amendment No. 1”) to the Company’s Registration Statement on Form S-1. Concurrent herewith, we are filing Amendment No. 2 to the Company’s Registration Statement reflecting the responses set forth below (the “Amended Registration Statement”)

For ease of reference, the comments contained in the Comment Letter are reproduced below and are followed by the Company’s response. All page references in the response set forth below refer to the page numbers in Amendment No. 1.

Registration Statement on Form S-1 filed July 1, 2021

Prospectus Cover Page, page 1

1. We note that a majority of your executive officers and directors are located in or have significant ties to China or Hong Kong.  Please disclose this prominently on the prospectus cover page.  Your disclosure also should describe the legal and operational risks associated with being based in or acquiring a company that does business in China.  Your disclosure should make clear whether these risks could result in a material change in your or the target company’s post-combination operations or the value of your common stock or could significantly limit or completely hinder your ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless.  Your disclosure should address how recent statements and regulatory actions by China’s government, such as those related to the use of variable interest entities and data security or anti-monopoly concerns, has or may impact the company’s ability to conduct its business, accept foreign investments, or list on an U.S. or other foreign exchange.  Your prospectus summary should address, but not necessarily be limited to, the risks highlighted on the prospectus cover page.

The Cover Page and Prospectus Summary have been revised in accordance with the Staff’s comment.

Los Angeles     New York     Chicago     Nashville     Washington, DC     Beijing     Hong Kong     www.loeb.com

A limited liability partnership including professional corporations

John Spitz Amit Pande September 23, 2021 Page 2

Prospectus Summary, page 1

2. Given that you may be seeking to acquire a company that uses or may use a variable interest entity structure to conduct China-based operations, please describe what that organizational structure would entail.  Explain that the entity in which investors may hold their interest may not be the entity or entities through which the company’s operations may be conducted in China after the business combination.  Discuss how this type of corporate structure may affect investors and the value of their investment, including how and why the contractual arrangements may be less effective than direct ownership and that the company may incur substantial costs to enforce the terms of the arrangements.  Disclose the uncertainties regarding the status of the rights of a holding company with respect to its contractual arrangements with a VIE, its founders and owners and the challenges the company may face enforcing these contractual agreements due to uncertainties under Chinese law and jurisdictional limits. 

The Prospectus Summary has been revised in accordance with the Staff’s comment.

3. In your summary of risk factors, disclose the risks that being based in or acquiring a company whose corporate structure or whose operations in China poses to investors.  In particular, describe the significant regulatory, liquidity, and enforcement risks with cross-references to the more detailed discussion of these risks in the prospectus.  For example, specifically discuss risks arising from the legal system in China, including risks and uncertainties regarding the enforcement of laws and that rules and regulations in China can change quickly with little advance notice; and the risk that the Chinese government may intervene or influence your operations at any time, or may exert more control over offerings conducted overseas and/or foreign investment in China-based issuers, which could result in a material change in your operations and/or the value of your common stock.  Acknowledge any risks that any actions by the Chinese government to exert more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers could significantly limit or completely hinder your ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless.

The Amended Registration Statement has been revised in accordance with the Staff’s comment.

4. Disclose each permission that you are required to obtain from Chinese authorities to operate and issue these securities to foreign investors.  State affirmatively whether you have received all requisite permissions and whether any permissions have been denied.

The Amended Registration Statement has been revised in accordance with the Staff’s comment.

5. Provide a clear description of how cash will be transferred through the post-combination organization if you acquire a company based in China.  Describe any restrictions on foreign exchange and your ability to transfer cash between entities, across borders, and to U.S. investors that may apply after a business combination with a company based in China.  Describe any restrictions and limitations on your ability to distribute earningsmfrom your businesses, including subsidiaries and consolidated VIEs, to the parent company and U.S. investors as well as the ability to settle amounts owed under the VIE agreements. 

The Amended Registration Statement has been revised in accordance with the Staff’s comment.

6. Disclose that trading in your securities may be prohibited under the Holding Foreign Companies Accountable Act if the PCAOB determines that it cannot inspect or fully investigate your auditor or the auditor of a company you may target for an initial business combination, and that as a result an exchange may determine to delist your securities. If the PCAOB has been or is currently unable to inspect your auditor, revise your disclosure to so state.

The Amended Registration Statement has been revised in accordance with the Staff’s comment.

John Spitz Amit Pande September 23, 2021 Page 3

Risk Factors, page 31

7. To the extent that you may acquire a company that uses or may use a variable interest entity structure to conduct China-based operations, please revise your risk factors to acknowledge that if the PRC government determines that the contractual arrangements constituting part of your VIE structure do not comply with PRC regulations, or if these regulations change or are interpreted differently in the future, your shares may decline in value or be worthless if you are unable to assert your contractual control rights over the assets of your PRC subsidiaries that may conduct all or substantially all of your operations.

The Amended Registration Statement has been revised in accordance with the Staff’s comment.

8. Please expand your risk factor disclosure to address specifically any PRC regulations concerning mergers and acquisitions by foreign investors that your initial business combination transaction may be subject to, including PRC regulatory reviews, which may impact your ability to complete a business combination in the prescribed time period.

The Amended Registration Statement has been revised in accordance with the Staff’s comment.

9. Given the Chinese government’s significant oversight and discretion over the conduct of the business of any China-based company that you may target for an initial business combination, please revise to separately highlight the risk that the Chinese government may intervene or influence your operations at any time, which could result in a material change in your operations and/or the value of your common stock.  Also, given recent statements by the Chinese government indicating an intent to exert more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers, acknowledge the risk that any such action could significantly limit or completely hinder your ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless.

The Amended Registration Statement has been revised in accordance with the Staff’s comment.

10. In light of recent events indicating greater oversight by the Cyberspace Administration of China over data security, particularly for companies seeking to list on a foreign exchange, please revise your disclosure to explain how this oversight could impact the process of searching for a target and completing an initial business combination, and/or your business on a post-combination basis. 

The Amended Registration Statement has been revised in accordance with the Staff’s comment.

Exhibits

11. Refer to your response to comments 3 and 4 that you have revised Exhibits 4.5 and 4.6.  It does not appear that you have refiled these exhibits.  Please ensure that the exclusive forum provision in the warrant agreement filed as Exhibit 4.5 states that it does not apply to actions arising under the Securities Act or tell us how you will inform investors in future filings that the provision does not apply to any actions arising under the Securities Act.  In addition, please ensure that the exclusive forum provision in the Rights Agreement filed as Exhibit 4.6 clearly states that it does not apply to actions arising under the Exchange Act or the Securities Act or tell us how you will inform investors in future filings that the provision does not apply to any actions arising under the Exchange Act or Securities Act.

The Amended Registration Statement has been revised in accordance with the Staff’s comment.

John Spitz Amit Pande September 23, 2021 Page 4

Please call me at 212 407-4866 if you would like additional information with respect to any of the foregoing. Thank you.

Sincerely,

/s/ Giovanni Caruso

Giovanni Caruso
Partner